Transforming tissue-based translational research with advanced multiplexing technologies, image analysis and cloud collaboration
Dr. Sean Downing, PhD | Director Customer Engagement, Ultivue
25 October, 2018
8:00 PDT | 11:00 EDT | 16:00 BST | 17:00 CEST
With its high spatial heterogeneity and biological complexity, the tumor immune microenvironment presents a characterization challenge for translational researchers. Conventional immunohistochemistry (IHC) methods only provide insight into a limited number of markers of interest. In this 60-minute webinar, Dr. Sean Downing from Ultivue will explain how they are overcoming these limitations and extracting meaningful, highly multiplexed biomarker data from whole slide images using Ultivue’s proprietary multiplexing technology, UltiMapper™ I/O, in combination with the HALO® image analysis platform. He will describe how Ultivue’s technology works with existing stains and scanners, and finally, how Ultivue utilizes HALO LINK™ as its digital image management tool to facilitate remote access to biomarker data and secure file sharing with its customers across the world.
- Learn about Ultivue’s unique multiplexing technology and offerings, including UltiMapper™ I/O kit.
- Understand how these technologies integrate with existing histology workflows.
- See how HALO and HALO Link are used by the R&D and Services Team within Ultivue.